The global market for Infusion Pumps is estimated at US$13.9 Billion in 2023 and is projected to reach US$19.2 Billion by 2030, growing at a CAGR of 4.6% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The growth in the infusion pumps market is driven by several factors, including the increasing prevalence of chronic diseases such as diabetes, cancer, and chronic pain, which necessitate continuous and precise medication delivery. The rising geriatric population, more susceptible to chronic illnesses, further accelerates market demand. Technological innovations, such as the integration of wireless technology and advanced safety features, enhance the usability and reliability of infusion pumps, driving their adoption in both clinical and home settings. The growing trend towards home healthcare and outpatient care, driven by the need to reduce hospital stays and associated healthcare costs, expands the market for portable and wearable infusion pumps. Additionally, favorable reimbursement policies and increased healthcare spending in emerging economies contribute to the market`s expansion. The emphasis on improving patient safety and cost-effectiveness within healthcare systems worldwide further bolsters the demand for advanced infusion pump systems. As these trends continue, the infusion pumps market is poised for significant growth, supported by technological advancements and a growing focus on enhancing patient care and operational efficiency.
The growth in the infusion pumps market is driven by several factors, including the increasing prevalence of chronic diseases such as diabetes, cancer, and chronic pain, which necessitate continuous and precise medication delivery. The rising geriatric population, more susceptible to chronic illnesses, further accelerates market demand. Technological innovations, such as the integration of wireless technology and advanced safety features, enhance the usability and reliability of infusion pumps, driving their adoption in both clinical and home settings. The growing trend towards home healthcare and outpatient care, driven by the need to reduce hospital stays and associated healthcare costs, expands the market for portable and wearable infusion pumps. Additionally, favorable reimbursement policies and increased healthcare spending in emerging economies contribute to the market`s expansion. The emphasis on improving patient safety and cost-effectiveness within healthcare systems worldwide further bolsters the demand for advanced infusion pump systems. As these trends continue, the infusion pumps market is poised for significant growth, supported by technological advancements and a growing focus on enhancing patient care and operational efficiency.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Volumetric Infusion Pumps segment, which is expected to reach US$2.2 Billion by 2030 with a CAGR of a 4.8%. The Insulin Infusion Pumps segment is also set to grow at 4.7% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $3.6 Billion in 2023, and China, forecasted to grow at an impressive 7.7% CAGR to reach $4.5 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Infusion Pumps Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Infusion Pumps Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Infusion Pumps Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Animas Corporation, B. Braun Melsungen AG, Baxter International Inc., and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 21 Featured):
- Animas Corporation
- B. Braun Melsungen AG
- Baxter International Inc.
- Becton, Dickinson and Company
- F. Hoffmann-La Roche Ltd.
- Fresenius SE & Co. KGaA
- Halyard Health Inc.
- Hospira Inc.
- ICU Medical Inc.
- Insulet Corporation
- Medtronic Plc
- Moog Inc.
- Smiths Medical
- Sooil Development Co. Ltd.
- Tandem Diabetes Care Inc.
- Teleflex Inc.
- Terumo Corporation
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISCANADAITALYSPAINRUSSIAREST OF EUROPESOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Animas Corporation
- B. Braun Melsungen AG
- Baxter International Inc.
- Becton, Dickinson and Company
- F. Hoffmann-La Roche Ltd.
- Fresenius SE & Co. KGaA
- Halyard Health Inc.
- Hospira Inc.
- ICU Medical Inc.
- Insulet Corporation
- Medtronic Plc
- Moog Inc.
- Smiths Medical
- Sooil Development Co. Ltd.
- Tandem Diabetes Care Inc.
- Teleflex Inc.
- Terumo Corporation
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 183 |
Published | November 2024 |
Forecast Period | 2023 - 2030 |
Estimated Market Value ( USD | $ 13.9 Billion |
Forecasted Market Value ( USD | $ 19.2 Billion |
Compound Annual Growth Rate | 4.6% |
Regions Covered | Global |